share_log

IN8bio Q1 2024 GAAP EPS $(0.20) Misses $(0.18) Estimate

Benzinga ·  May 9 16:26

IN8bio (NASDAQ:INAB) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.18) by 11.11 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment